Galmed Pharmaceuticals (GLMD) Revenue (2016 - 2018)

Galmed Pharmaceuticals has reported Revenue for 3 years, with the latest figure at $1.5 million in Q3 2018.

• On a quarterly basis, Revenue rose 449.45% year-over-year to $1.5 million in Q3 2018; TTM through Jun 2019 was $1.8 million, a 63.13% increase from a year earlier, with the FY2018 full-year figure at $2.0 million, up 87.83% from the prior year.
• Revenue was $1.5 million for Q3 2018 at Galmed Pharmaceuticals, up from $270000.0 in the prior quarter.
• The five-year high for Revenue was $1.5 million in Q3 2018, with the low at $193000.0 in Q3 2016.
• Average Revenue over 3 years is $398888.9, with a median of $270000.0 recorded in 2017.
• The sharpest annual moves came in 2017 and 2018: Revenue changed 0.0% in 2017, then surged 449.45% in 2018.
• Over 3 years, Revenue stood at $274000.0 in 2016, then changed by 0.0% to $274000.0 in 2017, then surged by 447.45% to $1.5 million in 2018.
• The last three Revenue figures came in at $1.5 million (Q3 2018), $270000.0 (Q2 2018), and $268000.0 (Q1 2018), per Business Quant data.